Kronilog-DS Tablet contains Alpha Ketoanalogue (NA), a specialized pharmaceutical agent used primarily as a nutritional supplement in the management of chronic kidney disease (CKD). Alpha Ketoanalogue serves as a nitrogen-free analog of essential amino acids, facilitating protein metabolism while minimizing nitrogenous waste production, thereby reducing the burden on compromised renal function. Kronilog-DS is indicated for patients with advanced CKD who require dietary protein restriction to slow disease progression and prevent metabolic complications such as uremia. By providing essential ketoanalogues, the tablet supports endogenous amino acid synthesis, helping to maintain nutritional status without exacerbating azotemia. The formulation is designed to be administered orally, typically in conjunction with a low-protein diet under medical supervision. Clinical use of Kronilog-DS has demonstrated benefits in improving nutritional parameters, delaying the need for dialysis, and enhancing overall patient outcomes in renal insufficiency. It is contraindicated in patients with hypersensitivity to any component of the formulation or those with severe hepatic impairment. Adverse effects are generally mild and may include gastrointestinal disturbances. Regular monitoring of renal function and nutritional status is recommended during therapy to optimize dosing and ensure safety. Kronilog-DS should be prescribed and used according to professional medical guidelines.